NEWPORT NEWS, Va., Nov. 19 /PRNewswire/ -- Breast-Specific Gamma Imaging/Molecular Breast Imaging (BSGI/MBI) has been recognized and endorsed by two highly esteemed organizations for the fight against breast cancer: The Society of Breast Imaging (SBI) and the American College of Surgeons. Both societies published articles supporting the further application of this breakthrough imaging technology for the early detection of breast cancer.
In the Fall 2009 issue of the SBI News, the article, "Nuclear Medicine Breast Imaging: An Exciting Frontier," discusses the advancements in nuclear medicine imaging of the breast. According to the article, "nuclear medicine is an exciting field of development for breast imaging and will almost certainly lead to improved detection of breast cancer in the future."
The Consensus Conference III panel, formed by the American College of Surgeons, concluded in a special report that BSGI may have equal sensitivity and improved specificity when compared with breast MRI. The panel also concluded that BSGI and positron emission mammography (PEM) may be used as alternatives to breast MRI when MRI is not available or is contraindicated in certain patients. The panel also agreed that in some situations, BSGI may be useful as an additional problem-solving tool.
Dilon Diagnostics(R), makers of the Dilon 6800(R) Gamma Camera optimized for BSGI, welcomes the growing acceptance and adoption of the technology for breast cancer imaging as a standard of care.
About Dilon Diagnostics
Dilon Diagnostics, a brand of Dilon Technologies Inc., is bringing innovative medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, compact gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Diagnostics please visit www.dilon.com.